The range provides disinfection of external non-porous surfaces of medical equipment and devices prior to sterilisation in a multitude of healthcare environments.
‘Effective against 99.9% of bacteria as well as viruses and fungi, micro-organisms such as C. Difficile, MRSA, and the H1N1 influenza virus are destroyed, making Pal Disinfectant wipes ideal in preventing cross-contamination and limiting hospital acquired infections,’ Pal reports.
The firm also provides 70% alcohol and Chlorhexidine disinfectant wipes, ‘all with proven efficacy against numerous bacteria, viruses and micro-organisms’.
‘Convenient to use and available in various types of packaging, Pal wipes deliver the correct dose of pre-mixed disinfectant solution to the surface, and do not require rinsing. Their single-use application — each should be disposed of after use — ensures cross-contamination risks are further reduced.’
Pal invests heavily in its accreditation to prove the product efficacy of wipes; they are independently tested by approved organizations such as Blu Scientific (Glasgow Caledonian University), City Hospital Birmingham and Campden & Chorleywood Food Research Association.
‘With Pal’s team of technicians and microbiologists continually developing standard and bespoke products in the in-house laboratories based at our Head Office, speed of reaction to customer demands is a priority,’ Pal explains. ‘As hygiene legislation becomes tougher, Pal exceeds the rigorous demands and produces wiping systems that are both effective and safe for healthcare use.’
The company, which has manufactured a wide range of hygiene products and protective clothing for over three decades, now supplies products to over 70 countries worldwide.